Radisens is developing a high sensitivity, quantitative point-of-care (PoC) in-vitro diagnostics platform – Gemini™ – to measure ferritin (iron stores) as a screen for iron deficiency. The platform uses a fingerstick blood sample, and…

Radisens is developing a professional-use only, point-of-care (PoC) in-vitro diagnostics platform – Gemini™ – to quantify ferritin levels. Gemini™ consists of an optical-based reader which automatically tests a latex enhanced homo…

Radisens has a business-to-business commercial approach and seek to develop strategic partnerships. These include technology licensing, strategic investment, manufacturing and distribution relationships with collaborators to …